Applied Clinical Trials
February 14, 2018
Feature Article
27
2
Outlining the growing attention and pursuits around social media in adverse event reporting and advancing patient-centric initiatives in clinical trials.
February 01, 2018
News
27
2
Now the challenge to FDA and to sponsors is to maintain the high level of support for research, discovery, and regulatory flexibility underpinning these gains, writes Jill Wechsler.
February 01, 2018
News
27
2
Peter O’Donnell looks at efforts in Europe to improve R&D communication and trust with investors and the public.
February 01, 2018
News
27
2
An expert view on how sponsors can formalize the use of real-world data and generation of real-world evidence to drive critical insights.
February 01, 2018
Feature Article
27
2
Examining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
February 01, 2018
A Closing Thought
27
2
To vie for success in the market for dermatologic therapies, companies developing biologics must navigate a series of significant challenges, including patient compliance and safety.
February 01, 2018
CISCRP Corner
27
2
The first series of results from the Center for Information and Study on Clinical Research Participation’s (CISCRP) landmark 2017 Perceptions & Insights Study.
February 01, 2018
Survey Spotlight
27
2
Findings from a new ACT and SCORR Marketing survey reveal a gap in the shift to true patient-engagement in clinical trials, but overall measures do signal growth in patient-centric activities.
February 01, 2018
From the Editor
27
2
Lisa Henderson reports on the J.P. Morgan Healthcare conference and the balance of investment and science.
January 01, 2018
Issue PDF
27
2
Click the title above to open the Applied Clinical Trials January/February 2018 issue in an interactive PDF format.